nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—bone cancer—thyroid cancer	0.2	0.399	CtDrD
Cisplatin—germ cell cancer—thyroid cancer	0.159	0.317	CtDrD
Cisplatin—lung cancer—thyroid cancer	0.143	0.285	CtDrD
Cisplatin—PTGS2—thyroid cancer	0.111	1	CbGaD
Cisplatin—NQO1—Doxorubicin—thyroid cancer	0.0517	0.213	CbGbCtD
Cisplatin—ABCC6—Doxorubicin—thyroid cancer	0.0432	0.178	CbGbCtD
Cisplatin—XDH—Doxorubicin—thyroid cancer	0.027	0.111	CbGbCtD
Cisplatin—ABCG2—Vandetanib—thyroid cancer	0.0233	0.0961	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—thyroid cancer	0.0208	0.0855	CbGbCtD
Cisplatin—ABCC2—Sorafenib—thyroid cancer	0.0156	0.064	CbGbCtD
Cisplatin—ABCG2—Sorafenib—thyroid cancer	0.0141	0.0579	CbGbCtD
Cisplatin—CYP2B6—Sorafenib—thyroid cancer	0.00989	0.0407	CbGbCtD
Cisplatin—ABCC2—Doxorubicin—thyroid cancer	0.00944	0.0389	CbGbCtD
Cisplatin—ABCG2—Doxorubicin—thyroid cancer	0.00853	0.0351	CbGbCtD
Cisplatin—CYP2B6—Doxorubicin—thyroid cancer	0.006	0.0247	CbGbCtD
Cisplatin—CYP2C9—Sorafenib—thyroid cancer	0.00522	0.0215	CbGbCtD
Cisplatin—ABCB1—Sorafenib—thyroid cancer	0.00507	0.0209	CbGbCtD
Cisplatin—ABCB1—Doxorubicin—thyroid cancer	0.00308	0.0127	CbGbCtD
Cisplatin—MT2A—Erlotinib—Vandetanib—thyroid cancer	0.002	1	CbGdCrCtD
Cisplatin—GSTT1—neck—thyroid cancer	0.00148	0.0462	CbGeAlD
Cisplatin—SLC31A2—saliva-secreting gland—thyroid cancer	0.00116	0.0362	CbGeAlD
Cisplatin—GSTM1—neck—thyroid cancer	0.00109	0.034	CbGeAlD
Cisplatin—ATP7A—saliva-secreting gland—thyroid cancer	0.00102	0.0319	CbGeAlD
Cisplatin—ATP7B—trachea—thyroid cancer	0.000979	0.0305	CbGeAlD
Cisplatin—SLC31A2—trachea—thyroid cancer	0.000894	0.0279	CbGeAlD
Cisplatin—SOD1—saliva-secreting gland—thyroid cancer	0.000894	0.0279	CbGeAlD
Cisplatin—SLC31A1—saliva-secreting gland—thyroid cancer	0.000871	0.0272	CbGeAlD
Cisplatin—MT1A—thyroid gland—thyroid cancer	0.000864	0.027	CbGeAlD
Cisplatin—ATP7A—trachea—thyroid cancer	0.000788	0.0246	CbGeAlD
Cisplatin—NQO1—neck—thyroid cancer	0.000764	0.0238	CbGeAlD
Cisplatin—SLC31A2—thyroid gland—thyroid cancer	0.000707	0.0221	CbGeAlD
Cisplatin—GSTT1—thyroid gland—thyroid cancer	0.000704	0.022	CbGeAlD
Cisplatin—SOD1—trachea—thyroid cancer	0.000689	0.0215	CbGeAlD
Cisplatin—ATP7B—head—thyroid cancer	0.000687	0.0214	CbGeAlD
Cisplatin—GSTP1—neck—thyroid cancer	0.000683	0.0213	CbGeAlD
Cisplatin—SLC31A1—trachea—thyroid cancer	0.000672	0.021	CbGeAlD
Cisplatin—MT2A—head—thyroid cancer	0.000638	0.0199	CbGeAlD
Cisplatin—SLC31A2—head—thyroid cancer	0.000627	0.0196	CbGeAlD
Cisplatin—GSTT1—head—thyroid cancer	0.000625	0.0195	CbGeAlD
Cisplatin—ATP7A—thyroid gland—thyroid cancer	0.000623	0.0195	CbGeAlD
Cisplatin—NQO1—saliva-secreting gland—thyroid cancer	0.000596	0.0186	CbGeAlD
Cisplatin—ABCC6—thyroid gland—thyroid cancer	0.000572	0.0178	CbGeAlD
Cisplatin—SOD1—thyroid gland—thyroid cancer	0.000545	0.017	CbGeAlD
Cisplatin—MT1A—lymph node—thyroid cancer	0.000537	0.0168	CbGeAlD
Cisplatin—GSTP1—saliva-secreting gland—thyroid cancer	0.000532	0.0166	CbGeAlD
Cisplatin—SLC31A1—thyroid gland—thyroid cancer	0.000532	0.0166	CbGeAlD
Cisplatin—GSTM1—thyroid gland—thyroid cancer	0.000519	0.0162	CbGeAlD
Cisplatin—ABCC6—head—thyroid cancer	0.000507	0.0158	CbGeAlD
Cisplatin—ATP7B—lymph node—thyroid cancer	0.000481	0.015	CbGeAlD
Cisplatin—SLC31A1—head—thyroid cancer	0.000472	0.0147	CbGeAlD
Cisplatin—GSTM1—head—thyroid cancer	0.00046	0.0144	CbGeAlD
Cisplatin—NQO1—trachea—thyroid cancer	0.00046	0.0143	CbGeAlD
Cisplatin—SLC31A2—lymph node—thyroid cancer	0.000439	0.0137	CbGeAlD
Cisplatin—GSTP1—trachea—thyroid cancer	0.000411	0.0128	CbGeAlD
Cisplatin—ABCC5—thyroid gland—thyroid cancer	0.000389	0.0121	CbGeAlD
Cisplatin—ATP7A—lymph node—thyroid cancer	0.000387	0.0121	CbGeAlD
Cisplatin—NQO1—thyroid gland—thyroid cancer	0.000364	0.0114	CbGeAlD
Cisplatin—SOD1—lymph node—thyroid cancer	0.000339	0.0106	CbGeAlD
Cisplatin—SLC31A1—lymph node—thyroid cancer	0.00033	0.0103	CbGeAlD
Cisplatin—ABCC3—thyroid gland—thyroid cancer	0.000326	0.0102	CbGeAlD
Cisplatin—GSTP1—thyroid gland—thyroid cancer	0.000325	0.0101	CbGeAlD
Cisplatin—NQO1—head—thyroid cancer	0.000323	0.0101	CbGeAlD
Cisplatin—GSTM1—lymph node—thyroid cancer	0.000322	0.0101	CbGeAlD
Cisplatin—ABCG2—saliva-secreting gland—thyroid cancer	0.000312	0.00973	CbGeAlD
Cisplatin—MPO—head—thyroid cancer	0.000297	0.00926	CbGeAlD
Cisplatin—ABCC3—head—thyroid cancer	0.00029	0.00904	CbGeAlD
Cisplatin—GSTP1—head—thyroid cancer	0.000288	0.009	CbGeAlD
Cisplatin—BCHE—trachea—thyroid cancer	0.000249	0.00776	CbGeAlD
Cisplatin—ABCC5—lymph node—thyroid cancer	0.000241	0.00754	CbGeAlD
Cisplatin—Optic neuritis—Epirubicin—thyroid cancer	0.000228	0.00308	CcSEcCtD
Cisplatin—Serum creatinine increased—Epirubicin—thyroid cancer	0.000228	0.00308	CcSEcCtD
Cisplatin—NQO1—lymph node—thyroid cancer	0.000226	0.00705	CbGeAlD
Cisplatin—Hypophosphataemia—Doxorubicin—thyroid cancer	0.000223	0.00302	CcSEcCtD
Cisplatin—Generalised oedema—Doxorubicin—thyroid cancer	0.000218	0.00295	CcSEcCtD
Cisplatin—Febrile neutropenia—Doxorubicin—thyroid cancer	0.000216	0.00292	CcSEcCtD
Cisplatin—Convulsion—Vandetanib—thyroid cancer	0.000213	0.00288	CcSEcCtD
Cisplatin—Optic neuritis—Doxorubicin—thyroid cancer	0.000211	0.00285	CcSEcCtD
Cisplatin—Serum creatinine increased—Doxorubicin—thyroid cancer	0.000211	0.00285	CcSEcCtD
Cisplatin—Acute coronary syndrome—Sorafenib—thyroid cancer	0.000209	0.00283	CcSEcCtD
Cisplatin—Renal failure—Sorafenib—thyroid cancer	0.000209	0.00282	CcSEcCtD
Cisplatin—Anxiety—Vandetanib—thyroid cancer	0.000209	0.00282	CcSEcCtD
Cisplatin—Myocardial infarction—Sorafenib—thyroid cancer	0.000208	0.00282	CcSEcCtD
Cisplatin—Neuropathy peripheral—Sorafenib—thyroid cancer	0.000208	0.00282	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.000208	0.00281	CcSEcCtD
Cisplatin—MPO—lymph node—thyroid cancer	0.000208	0.00648	CbGeAlD
Cisplatin—Stomatitis—Sorafenib—thyroid cancer	0.000207	0.0028	CcSEcCtD
Cisplatin—ABCC3—lymph node—thyroid cancer	0.000203	0.00633	CbGeAlD
Cisplatin—GSTP1—lymph node—thyroid cancer	0.000202	0.0063	CbGeAlD
Cisplatin—Hepatobiliary disease—Sorafenib—thyroid cancer	0.000201	0.00272	CcSEcCtD
Cisplatin—Oedema—Vandetanib—thyroid cancer	0.000201	0.00272	CcSEcCtD
Cisplatin—Infection—Vandetanib—thyroid cancer	0.000199	0.0027	CcSEcCtD
Cisplatin—BCHE—thyroid gland—thyroid cancer	0.000197	0.00614	CbGeAlD
Cisplatin—Nervous system disorder—Vandetanib—thyroid cancer	0.000197	0.00266	CcSEcCtD
Cisplatin—Thrombocytopenia—Vandetanib—thyroid cancer	0.000196	0.00266	CcSEcCtD
Cisplatin—Skin disorder—Vandetanib—thyroid cancer	0.000195	0.00264	CcSEcCtD
Cisplatin—PTGS2—trachea—thyroid cancer	0.000192	0.00598	CbGeAlD
Cisplatin—ABCG2—thyroid gland—thyroid cancer	0.00019	0.00594	CbGeAlD
Cisplatin—Urinary tract disorder—Sorafenib—thyroid cancer	0.000188	0.00255	CcSEcCtD
Cisplatin—Connective tissue disorder—Sorafenib—thyroid cancer	0.000187	0.00253	CcSEcCtD
Cisplatin—Urethral disorder—Sorafenib—thyroid cancer	0.000187	0.00253	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000183	0.00247	CcSEcCtD
Cisplatin—Paraesthesia—Vandetanib—thyroid cancer	0.00018	0.00244	CcSEcCtD
Cisplatin—Dyspnoea—Vandetanib—thyroid cancer	0.000179	0.00242	CcSEcCtD
Cisplatin—Necrosis—Epirubicin—thyroid cancer	0.000179	0.00242	CcSEcCtD
Cisplatin—Tinnitus—Sorafenib—thyroid cancer	0.000178	0.0024	CcSEcCtD
Cisplatin—Abscess—Epirubicin—thyroid cancer	0.000177	0.0024	CcSEcCtD
Cisplatin—Cardiac disorder—Sorafenib—thyroid cancer	0.000177	0.00239	CcSEcCtD
Cisplatin—Flushing—Sorafenib—thyroid cancer	0.000177	0.00239	CcSEcCtD
Cisplatin—BCHE—head—thyroid cancer	0.000175	0.00545	CbGeAlD
Cisplatin—Decreased appetite—Vandetanib—thyroid cancer	0.000174	0.00236	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000173	0.00234	CcSEcCtD
Cisplatin—Ageusia—Epirubicin—thyroid cancer	0.000173	0.00234	CcSEcCtD
Cisplatin—Immune system disorder—Sorafenib—thyroid cancer	0.000172	0.00233	CcSEcCtD
Cisplatin—Mediastinal disorder—Sorafenib—thyroid cancer	0.000172	0.00232	CcSEcCtD
Cisplatin—Pain—Vandetanib—thyroid cancer	0.000172	0.00232	CcSEcCtD
Cisplatin—Arrhythmia—Sorafenib—thyroid cancer	0.00017	0.0023	CcSEcCtD
Cisplatin—Alopecia—Sorafenib—thyroid cancer	0.000168	0.00228	CcSEcCtD
Cisplatin—Liver injury—Epirubicin—thyroid cancer	0.000167	0.00225	CcSEcCtD
Cisplatin—Erythema—Sorafenib—thyroid cancer	0.000166	0.00224	CcSEcCtD
Cisplatin—Malnutrition—Sorafenib—thyroid cancer	0.000166	0.00224	CcSEcCtD
Cisplatin—Necrosis—Doxorubicin—thyroid cancer	0.000165	0.00224	CcSEcCtD
Cisplatin—Abscess—Doxorubicin—thyroid cancer	0.000164	0.00222	CcSEcCtD
Cisplatin—ABCC2—lymph node—thyroid cancer	0.000162	0.00506	CbGeAlD
Cisplatin—Extravasation—Epirubicin—thyroid cancer	0.000161	0.00217	CcSEcCtD
Cisplatin—Ageusia—Doxorubicin—thyroid cancer	0.00016	0.00217	CcSEcCtD
Cisplatin—Muscle spasms—Sorafenib—thyroid cancer	0.000159	0.00216	CcSEcCtD
Cisplatin—Body temperature increased—Vandetanib—thyroid cancer	0.000159	0.00215	CcSEcCtD
Cisplatin—CYP2B6—head—thyroid cancer	0.000156	0.00486	CbGeAlD
Cisplatin—Cellulitis—Epirubicin—thyroid cancer	0.000154	0.00209	CcSEcCtD
Cisplatin—Liver injury—Doxorubicin—thyroid cancer	0.000154	0.00209	CcSEcCtD
Cisplatin—Anaemia—Sorafenib—thyroid cancer	0.000153	0.00207	CcSEcCtD
Cisplatin—Hyperuricaemia—Epirubicin—thyroid cancer	0.000151	0.00205	CcSEcCtD
Cisplatin—Extravasation—Doxorubicin—thyroid cancer	0.000149	0.00201	CcSEcCtD
Cisplatin—Leukopenia—Sorafenib—thyroid cancer	0.000148	0.00201	CcSEcCtD
Cisplatin—Ulcer—Epirubicin—thyroid cancer	0.000148	0.00201	CcSEcCtD
Cisplatin—Dysarthria—Epirubicin—thyroid cancer	0.000148	0.00201	CcSEcCtD
Cisplatin—Asthenia—Vandetanib—thyroid cancer	0.000144	0.00195	CcSEcCtD
Cisplatin—Blood uric acid increased—Epirubicin—thyroid cancer	0.000143	0.00193	CcSEcCtD
Cisplatin—Cellulitis—Doxorubicin—thyroid cancer	0.000143	0.00193	CcSEcCtD
Cisplatin—Myalgia—Sorafenib—thyroid cancer	0.000141	0.00191	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00014	0.0019	CcSEcCtD
Cisplatin—Hepatocellular injury—Epirubicin—thyroid cancer	0.00014	0.0019	CcSEcCtD
Cisplatin—Hiccups—Epirubicin—thyroid cancer	0.00014	0.0019	CcSEcCtD
Cisplatin—Hyperuricaemia—Doxorubicin—thyroid cancer	0.00014	0.00189	CcSEcCtD
Cisplatin—Hyperkalaemia—Epirubicin—thyroid cancer	0.000138	0.00186	CcSEcCtD
Cisplatin—Diarrhoea—Vandetanib—thyroid cancer	0.000137	0.00186	CcSEcCtD
Cisplatin—Dysarthria—Doxorubicin—thyroid cancer	0.000137	0.00186	CcSEcCtD
Cisplatin—Ulcer—Doxorubicin—thyroid cancer	0.000137	0.00186	CcSEcCtD
Cisplatin—Anaphylactic shock—Sorafenib—thyroid cancer	0.000135	0.00183	CcSEcCtD
Cisplatin—PTGS2—head—thyroid cancer	0.000134	0.0042	CbGeAlD
Cisplatin—Infection—Sorafenib—thyroid cancer	0.000134	0.00182	CcSEcCtD
Cisplatin—Skin exfoliation—Epirubicin—thyroid cancer	0.000134	0.00181	CcSEcCtD
Cisplatin—Fluid retention—Epirubicin—thyroid cancer	0.000133	0.0018	CcSEcCtD
Cisplatin—Nervous system disorder—Sorafenib—thyroid cancer	0.000133	0.0018	CcSEcCtD
Cisplatin—Thrombocytopenia—Sorafenib—thyroid cancer	0.000132	0.00179	CcSEcCtD
Cisplatin—Blood uric acid increased—Doxorubicin—thyroid cancer	0.000132	0.00179	CcSEcCtD
Cisplatin—Neuropathy—Epirubicin—thyroid cancer	0.000132	0.00178	CcSEcCtD
Cisplatin—Skin disorder—Sorafenib—thyroid cancer	0.000131	0.00178	CcSEcCtD
Cisplatin—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00013	0.00176	CcSEcCtD
Cisplatin—Hiccups—Doxorubicin—thyroid cancer	0.00013	0.00176	CcSEcCtD
Cisplatin—Anorexia—Sorafenib—thyroid cancer	0.000129	0.00175	CcSEcCtD
Cisplatin—Vomiting—Vandetanib—thyroid cancer	0.000128	0.00173	CcSEcCtD
Cisplatin—Hyperkalaemia—Doxorubicin—thyroid cancer	0.000127	0.00172	CcSEcCtD
Cisplatin—Rash—Vandetanib—thyroid cancer	0.000126	0.00171	CcSEcCtD
Cisplatin—Dermatitis—Vandetanib—thyroid cancer	0.000126	0.00171	CcSEcCtD
Cisplatin—Skin exfoliation—Doxorubicin—thyroid cancer	0.000124	0.00168	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000123	0.00167	CcSEcCtD
Cisplatin—Fluid retention—Doxorubicin—thyroid cancer	0.000123	0.00167	CcSEcCtD
Cisplatin—BCHE—lymph node—thyroid cancer	0.000122	0.00382	CbGeAlD
Cisplatin—Neuropathy—Doxorubicin—thyroid cancer	0.000122	0.00165	CcSEcCtD
Cisplatin—Dyspnoea—Sorafenib—thyroid cancer	0.000121	0.00163	CcSEcCtD
Cisplatin—Nausea—Vandetanib—thyroid cancer	0.000119	0.00161	CcSEcCtD
Cisplatin—ABCB1—trachea—thyroid cancer	0.000119	0.0037	CbGeAlD
Cisplatin—ABCG2—lymph node—thyroid cancer	0.000118	0.00369	CbGeAlD
Cisplatin—Phlebitis—Epirubicin—thyroid cancer	0.000118	0.0016	CcSEcCtD
Cisplatin—Decreased appetite—Sorafenib—thyroid cancer	0.000118	0.00159	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000117	0.00158	CcSEcCtD
Cisplatin—Pain—Sorafenib—thyroid cancer	0.000116	0.00157	CcSEcCtD
Cisplatin—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000112	0.00152	CcSEcCtD
Cisplatin—Renal failure acute—Epirubicin—thyroid cancer	0.00011	0.00149	CcSEcCtD
Cisplatin—Phlebitis—Doxorubicin—thyroid cancer	0.000109	0.00148	CcSEcCtD
Cisplatin—Body temperature increased—Sorafenib—thyroid cancer	0.000107	0.00145	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000105	0.00142	CcSEcCtD
Cisplatin—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000104	0.00141	CcSEcCtD
Cisplatin—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000104	0.00141	CcSEcCtD
Cisplatin—Hyponatraemia—Epirubicin—thyroid cancer	0.000102	0.00138	CcSEcCtD
Cisplatin—Renal failure acute—Doxorubicin—thyroid cancer	0.000102	0.00138	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000102	0.00138	CcSEcCtD
Cisplatin—Hypersensitivity—Sorafenib—thyroid cancer	9.97e-05	0.00135	CcSEcCtD
Cisplatin—Face oedema—Epirubicin—thyroid cancer	9.82e-05	0.00133	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Doxorubicin—thyroid cancer	9.73e-05	0.00132	CcSEcCtD
Cisplatin—Asthenia—Sorafenib—thyroid cancer	9.71e-05	0.00131	CcSEcCtD
Cisplatin—Cerebrovascular accident—Doxorubicin—thyroid cancer	9.61e-05	0.0013	CcSEcCtD
Cisplatin—Blood creatinine increased—Epirubicin—thyroid cancer	9.53e-05	0.00129	CcSEcCtD
Cisplatin—Dehydration—Epirubicin—thyroid cancer	9.46e-05	0.00128	CcSEcCtD
Cisplatin—Hyponatraemia—Doxorubicin—thyroid cancer	9.45e-05	0.00128	CcSEcCtD
Cisplatin—PTGS2—lymph node—thyroid cancer	9.42e-05	0.00294	CbGeAlD
Cisplatin—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	9.42e-05	0.00127	CcSEcCtD
Cisplatin—ABCB1—thyroid gland—thyroid cancer	9.38e-05	0.00293	CbGeAlD
Cisplatin—Orthostatic hypotension—Epirubicin—thyroid cancer	9.29e-05	0.00126	CcSEcCtD
Cisplatin—Hypokalaemia—Epirubicin—thyroid cancer	9.26e-05	0.00125	CcSEcCtD
Cisplatin—Diarrhoea—Sorafenib—thyroid cancer	9.26e-05	0.00125	CcSEcCtD
Cisplatin—Breast disorder—Epirubicin—thyroid cancer	9.2e-05	0.00124	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	9.16e-05	0.00124	CcSEcCtD
Cisplatin—Nasopharyngitis—Epirubicin—thyroid cancer	9.1e-05	0.00123	CcSEcCtD
Cisplatin—Face oedema—Doxorubicin—thyroid cancer	9.09e-05	0.00123	CcSEcCtD
Cisplatin—Blood creatinine increased—Doxorubicin—thyroid cancer	8.82e-05	0.00119	CcSEcCtD
Cisplatin—Dehydration—Doxorubicin—thyroid cancer	8.76e-05	0.00119	CcSEcCtD
Cisplatin—Pancreatitis—Epirubicin—thyroid cancer	8.62e-05	0.00117	CcSEcCtD
Cisplatin—Vomiting—Sorafenib—thyroid cancer	8.6e-05	0.00116	CcSEcCtD
Cisplatin—Orthostatic hypotension—Doxorubicin—thyroid cancer	8.6e-05	0.00116	CcSEcCtD
Cisplatin—Hypokalaemia—Doxorubicin—thyroid cancer	8.57e-05	0.00116	CcSEcCtD
Cisplatin—Rash—Sorafenib—thyroid cancer	8.53e-05	0.00115	CcSEcCtD
Cisplatin—Dermatitis—Sorafenib—thyroid cancer	8.52e-05	0.00115	CcSEcCtD
Cisplatin—Breast disorder—Doxorubicin—thyroid cancer	8.51e-05	0.00115	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	8.48e-05	0.00115	CcSEcCtD
Cisplatin—Nasopharyngitis—Doxorubicin—thyroid cancer	8.42e-05	0.00114	CcSEcCtD
Cisplatin—Pancytopenia—Epirubicin—thyroid cancer	8.35e-05	0.00113	CcSEcCtD
Cisplatin—ABCB1—head—thyroid cancer	8.32e-05	0.0026	CbGeAlD
Cisplatin—Nausea—Sorafenib—thyroid cancer	8.04e-05	0.00109	CcSEcCtD
Cisplatin—Pancreatitis—Doxorubicin—thyroid cancer	7.98e-05	0.00108	CcSEcCtD
Cisplatin—Pancytopenia—Doxorubicin—thyroid cancer	7.73e-05	0.00105	CcSEcCtD
Cisplatin—Renal failure—Epirubicin—thyroid cancer	7.71e-05	0.00104	CcSEcCtD
Cisplatin—Neuropathy peripheral—Epirubicin—thyroid cancer	7.69e-05	0.00104	CcSEcCtD
Cisplatin—Stomatitis—Epirubicin—thyroid cancer	7.64e-05	0.00103	CcSEcCtD
Cisplatin—Conjunctivitis—Epirubicin—thyroid cancer	7.62e-05	0.00103	CcSEcCtD
Cisplatin—Hepatobiliary disease—Epirubicin—thyroid cancer	7.42e-05	0.001	CcSEcCtD
Cisplatin—Bradycardia—Epirubicin—thyroid cancer	7.17e-05	0.00097	CcSEcCtD
Cisplatin—Renal failure—Doxorubicin—thyroid cancer	7.13e-05	0.000965	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—thyroid cancer	7.11e-05	0.000963	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—thyroid cancer	7.07e-05	0.000957	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—thyroid cancer	7.05e-05	0.000955	CcSEcCtD
Cisplatin—Urinary tract disorder—Epirubicin—thyroid cancer	6.95e-05	0.000941	CcSEcCtD
Cisplatin—Connective tissue disorder—Epirubicin—thyroid cancer	6.92e-05	0.000936	CcSEcCtD
Cisplatin—Urethral disorder—Epirubicin—thyroid cancer	6.9e-05	0.000934	CcSEcCtD
Cisplatin—Hepatobiliary disease—Doxorubicin—thyroid cancer	6.86e-05	0.000929	CcSEcCtD
Cisplatin—Visual impairment—Epirubicin—thyroid cancer	6.78e-05	0.000918	CcSEcCtD
Cisplatin—Bradycardia—Doxorubicin—thyroid cancer	6.63e-05	0.000897	CcSEcCtD
Cisplatin—Eye disorder—Epirubicin—thyroid cancer	6.58e-05	0.00089	CcSEcCtD
Cisplatin—Tinnitus—Epirubicin—thyroid cancer	6.56e-05	0.000888	CcSEcCtD
Cisplatin—Flushing—Epirubicin—thyroid cancer	6.53e-05	0.000884	CcSEcCtD
Cisplatin—Cardiac disorder—Epirubicin—thyroid cancer	6.53e-05	0.000884	CcSEcCtD
Cisplatin—Urinary tract disorder—Doxorubicin—thyroid cancer	6.43e-05	0.000871	CcSEcCtD
Cisplatin—Connective tissue disorder—Doxorubicin—thyroid cancer	6.4e-05	0.000866	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—thyroid cancer	6.38e-05	0.000864	CcSEcCtD
Cisplatin—Immune system disorder—Epirubicin—thyroid cancer	6.36e-05	0.000861	CcSEcCtD
Cisplatin—Mediastinal disorder—Epirubicin—thyroid cancer	6.34e-05	0.000859	CcSEcCtD
Cisplatin—Arrhythmia—Epirubicin—thyroid cancer	6.29e-05	0.000851	CcSEcCtD
Cisplatin—Visual impairment—Doxorubicin—thyroid cancer	6.28e-05	0.00085	CcSEcCtD
Cisplatin—Alopecia—Epirubicin—thyroid cancer	6.22e-05	0.000842	CcSEcCtD
Cisplatin—Erythema—Epirubicin—thyroid cancer	6.13e-05	0.000829	CcSEcCtD
Cisplatin—Malnutrition—Epirubicin—thyroid cancer	6.13e-05	0.000829	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—thyroid cancer	6.09e-05	0.000824	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—thyroid cancer	6.07e-05	0.000822	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—thyroid cancer	6.04e-05	0.000818	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—thyroid cancer	6.04e-05	0.000818	CcSEcCtD
Cisplatin—Flatulence—Epirubicin—thyroid cancer	6.04e-05	0.000817	CcSEcCtD
Cisplatin—Muscle spasms—Epirubicin—thyroid cancer	5.89e-05	0.000797	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—thyroid cancer	5.88e-05	0.000796	CcSEcCtD
Cisplatin—Mediastinal disorder—Doxorubicin—thyroid cancer	5.87e-05	0.000795	CcSEcCtD
Cisplatin—ABCB1—lymph node—thyroid cancer	5.82e-05	0.00182	CbGeAlD
Cisplatin—Arrhythmia—Doxorubicin—thyroid cancer	5.82e-05	0.000788	CcSEcCtD
Cisplatin—Vision blurred—Epirubicin—thyroid cancer	5.78e-05	0.000782	CcSEcCtD
Cisplatin—Alopecia—Doxorubicin—thyroid cancer	5.76e-05	0.000779	CcSEcCtD
Cisplatin—Ill-defined disorder—Epirubicin—thyroid cancer	5.69e-05	0.00077	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—thyroid cancer	5.67e-05	0.000767	CcSEcCtD
Cisplatin—Erythema—Doxorubicin—thyroid cancer	5.67e-05	0.000767	CcSEcCtD
Cisplatin—Anaemia—Epirubicin—thyroid cancer	5.66e-05	0.000767	CcSEcCtD
Cisplatin—Flatulence—Doxorubicin—thyroid cancer	5.59e-05	0.000756	CcSEcCtD
Cisplatin—Malaise—Epirubicin—thyroid cancer	5.53e-05	0.000748	CcSEcCtD
Cisplatin—Leukopenia—Epirubicin—thyroid cancer	5.49e-05	0.000742	CcSEcCtD
Cisplatin—Muscle spasms—Doxorubicin—thyroid cancer	5.45e-05	0.000738	CcSEcCtD
Cisplatin—Vision blurred—Doxorubicin—thyroid cancer	5.34e-05	0.000723	CcSEcCtD
Cisplatin—Convulsion—Epirubicin—thyroid cancer	5.31e-05	0.000719	CcSEcCtD
Cisplatin—Ill-defined disorder—Doxorubicin—thyroid cancer	5.26e-05	0.000712	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—thyroid cancer	5.24e-05	0.000709	CcSEcCtD
Cisplatin—Myalgia—Epirubicin—thyroid cancer	5.22e-05	0.000706	CcSEcCtD
Cisplatin—Anxiety—Epirubicin—thyroid cancer	5.2e-05	0.000704	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	5.18e-05	0.000701	CcSEcCtD
Cisplatin—Discomfort—Epirubicin—thyroid cancer	5.15e-05	0.000698	CcSEcCtD
Cisplatin—Malaise—Doxorubicin—thyroid cancer	5.11e-05	0.000692	CcSEcCtD
Cisplatin—Leukopenia—Doxorubicin—thyroid cancer	5.08e-05	0.000687	CcSEcCtD
Cisplatin—Oedema—Epirubicin—thyroid cancer	5e-05	0.000677	CcSEcCtD
Cisplatin—Anaphylactic shock—Epirubicin—thyroid cancer	5e-05	0.000677	CcSEcCtD
Cisplatin—Infection—Epirubicin—thyroid cancer	4.97e-05	0.000672	CcSEcCtD
Cisplatin—Convulsion—Doxorubicin—thyroid cancer	4.91e-05	0.000665	CcSEcCtD
Cisplatin—Nervous system disorder—Epirubicin—thyroid cancer	4.9e-05	0.000664	CcSEcCtD
Cisplatin—Thrombocytopenia—Epirubicin—thyroid cancer	4.9e-05	0.000663	CcSEcCtD
Cisplatin—Tachycardia—Epirubicin—thyroid cancer	4.88e-05	0.000661	CcSEcCtD
Cisplatin—Skin disorder—Epirubicin—thyroid cancer	4.86e-05	0.000658	CcSEcCtD
Cisplatin—Hyperhidrosis—Epirubicin—thyroid cancer	4.83e-05	0.000654	CcSEcCtD
Cisplatin—Myalgia—Doxorubicin—thyroid cancer	4.83e-05	0.000653	CcSEcCtD
Cisplatin—Anxiety—Doxorubicin—thyroid cancer	4.81e-05	0.000651	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	4.79e-05	0.000649	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—thyroid cancer	4.77e-05	0.000646	CcSEcCtD
Cisplatin—Anorexia—Epirubicin—thyroid cancer	4.77e-05	0.000645	CcSEcCtD
Cisplatin—Hypotension—Epirubicin—thyroid cancer	4.67e-05	0.000633	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—thyroid cancer	4.63e-05	0.000626	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—thyroid cancer	4.63e-05	0.000626	CcSEcCtD
Cisplatin—Infection—Doxorubicin—thyroid cancer	4.6e-05	0.000622	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	4.56e-05	0.000617	CcSEcCtD
Cisplatin—Nervous system disorder—Doxorubicin—thyroid cancer	4.54e-05	0.000614	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—thyroid cancer	4.53e-05	0.000613	CcSEcCtD
Cisplatin—Tachycardia—Doxorubicin—thyroid cancer	4.52e-05	0.000611	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—thyroid cancer	4.49e-05	0.000608	CcSEcCtD
Cisplatin—Paraesthesia—Epirubicin—thyroid cancer	4.49e-05	0.000608	CcSEcCtD
Cisplatin—Hyperhidrosis—Doxorubicin—thyroid cancer	4.47e-05	0.000605	CcSEcCtD
Cisplatin—Dyspnoea—Epirubicin—thyroid cancer	4.46e-05	0.000604	CcSEcCtD
Cisplatin—Anorexia—Doxorubicin—thyroid cancer	4.41e-05	0.000597	CcSEcCtD
Cisplatin—Decreased appetite—Epirubicin—thyroid cancer	4.35e-05	0.000588	CcSEcCtD
Cisplatin—Hypotension—Doxorubicin—thyroid cancer	4.32e-05	0.000585	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Epirubicin—thyroid cancer	4.32e-05	0.000584	CcSEcCtD
Cisplatin—Pain—Epirubicin—thyroid cancer	4.28e-05	0.000579	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	4.22e-05	0.000571	CcSEcCtD
Cisplatin—Paraesthesia—Doxorubicin—thyroid cancer	4.16e-05	0.000562	CcSEcCtD
Cisplatin—Dyspnoea—Doxorubicin—thyroid cancer	4.13e-05	0.000558	CcSEcCtD
Cisplatin—Feeling abnormal—Epirubicin—thyroid cancer	4.12e-05	0.000558	CcSEcCtD
Cisplatin—Decreased appetite—Doxorubicin—thyroid cancer	4.02e-05	0.000544	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	4e-05	0.000541	CcSEcCtD
Cisplatin—Pain—Doxorubicin—thyroid cancer	3.96e-05	0.000536	CcSEcCtD
Cisplatin—Body temperature increased—Epirubicin—thyroid cancer	3.95e-05	0.000535	CcSEcCtD
Cisplatin—Feeling abnormal—Doxorubicin—thyroid cancer	3.81e-05	0.000516	CcSEcCtD
Cisplatin—Hypersensitivity—Epirubicin—thyroid cancer	3.68e-05	0.000499	CcSEcCtD
Cisplatin—Body temperature increased—Doxorubicin—thyroid cancer	3.66e-05	0.000495	CcSEcCtD
Cisplatin—Asthenia—Epirubicin—thyroid cancer	3.59e-05	0.000486	CcSEcCtD
Cisplatin—Diarrhoea—Epirubicin—thyroid cancer	3.42e-05	0.000463	CcSEcCtD
Cisplatin—Hypersensitivity—Doxorubicin—thyroid cancer	3.41e-05	0.000461	CcSEcCtD
Cisplatin—Asthenia—Doxorubicin—thyroid cancer	3.32e-05	0.000449	CcSEcCtD
Cisplatin—Vomiting—Epirubicin—thyroid cancer	3.18e-05	0.00043	CcSEcCtD
Cisplatin—Diarrhoea—Doxorubicin—thyroid cancer	3.17e-05	0.000429	CcSEcCtD
Cisplatin—Rash—Epirubicin—thyroid cancer	3.15e-05	0.000427	CcSEcCtD
Cisplatin—Dermatitis—Epirubicin—thyroid cancer	3.15e-05	0.000426	CcSEcCtD
Cisplatin—Nausea—Epirubicin—thyroid cancer	2.97e-05	0.000402	CcSEcCtD
Cisplatin—Vomiting—Doxorubicin—thyroid cancer	2.94e-05	0.000398	CcSEcCtD
Cisplatin—Rash—Doxorubicin—thyroid cancer	2.92e-05	0.000395	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—thyroid cancer	2.92e-05	0.000395	CcSEcCtD
Cisplatin—Nausea—Doxorubicin—thyroid cancer	2.75e-05	0.000372	CcSEcCtD
Cisplatin—GSTP1—Metabolism—TPR—thyroid cancer	2.47e-05	0.000683	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.44e-05	0.000674	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PRKAR1A—thyroid cancer	2.43e-05	0.000672	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PRKAR1A—thyroid cancer	2.43e-05	0.000672	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NDUFA13—thyroid cancer	2.42e-05	0.000668	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—TPR—thyroid cancer	2.41e-05	0.000666	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	2.39e-05	0.000663	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NDUFA13—thyroid cancer	2.39e-05	0.000662	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PRKAR1A—thyroid cancer	2.37e-05	0.000655	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	2.35e-05	0.00065	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—BRAF—thyroid cancer	2.34e-05	0.000646	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MEN1—thyroid cancer	2.32e-05	0.000643	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CHST14—thyroid cancer	2.27e-05	0.000628	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CHST14—thyroid cancer	2.25e-05	0.000622	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	2.24e-05	0.000621	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	2.24e-05	0.000621	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—TPR—thyroid cancer	2.22e-05	0.000615	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—CP—thyroid cancer	2.22e-05	0.000615	CbGpPWpGaD
Cisplatin—BCHE—Phospholipid metabolism—PTEN—thyroid cancer	2.21e-05	0.000613	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.21e-05	0.000611	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TRIM24—thyroid cancer	2.2e-05	0.000609	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.19e-05	0.000605	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—TP53—thyroid cancer	2.18e-05	0.000604	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—SLC5A5—thyroid cancer	2.17e-05	0.000601	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—MINPP1—thyroid cancer	2.17e-05	0.0006	CbGpPWpGaD
Cisplatin—XDH—Metabolism—TPR—thyroid cancer	2.16e-05	0.000597	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.15e-05	0.000596	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.13e-05	0.000588	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PRKAR1A—thyroid cancer	2.12e-05	0.000587	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—BRAF—thyroid cancer	2.09e-05	0.000577	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—MINPP1—thyroid cancer	2.08e-05	0.000576	CbGpPWpGaD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.08e-05	0.000575	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	2.08e-05	0.000575	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—TPR—thyroid cancer	2.07e-05	0.000572	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CHST14—thyroid cancer	2.07e-05	0.000572	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.05e-05	0.000567	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PRKAR1A—thyroid cancer	2.03e-05	0.000563	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—HPGD—thyroid cancer	2.03e-05	0.000561	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	2.02e-05	0.00056	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TRIM33—thyroid cancer	1.96e-05	0.000543	CbGpPWpGaD
Cisplatin—CYP2C9—Biological oxidations—RXRA—thyroid cancer	1.95e-05	0.00054	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.93e-05	0.000535	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	1.92e-05	0.000532	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—TP53—thyroid cancer	1.9e-05	0.000527	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CALCA—thyroid cancer	1.85e-05	0.000512	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—SLC5A5—thyroid cancer	1.85e-05	0.000511	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NDUFA13—thyroid cancer	1.84e-05	0.00051	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—HPGD—thyroid cancer	1.83e-05	0.000507	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—RXRA—thyroid cancer	1.83e-05	0.000505	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—HPGD—thyroid cancer	1.81e-05	0.000501	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—SLC5A5—thyroid cancer	1.8e-05	0.000498	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—TPR—thyroid cancer	1.79e-05	0.000496	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—BRAF—thyroid cancer	1.79e-05	0.000495	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	1.79e-05	0.000495	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PPARG—thyroid cancer	1.79e-05	0.000495	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NDUFA13—thyroid cancer	1.77e-05	0.00049	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PRKAR1A—thyroid cancer	1.76e-05	0.000488	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	1.74e-05	0.000482	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CHST14—thyroid cancer	1.73e-05	0.000479	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—NRAS—thyroid cancer	1.7e-05	0.000469	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.68e-05	0.000465	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDK1—thyroid cancer	1.67e-05	0.000463	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CHST14—thyroid cancer	1.66e-05	0.000461	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.66e-05	0.00046	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.65e-05	0.000455	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.62e-05	0.000449	CbGpPWpGaD
Cisplatin—XDH—Metabolism—SLC5A5—thyroid cancer	1.61e-05	0.000447	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.6e-05	0.000443	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—BRAF—thyroid cancer	1.6e-05	0.000442	CbGpPWpGaD
Cisplatin—MT2A—Immune System—PTEN—thyroid cancer	1.56e-05	0.000431	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—RXRA—thyroid cancer	1.55e-05	0.00043	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—SLC5A5—thyroid cancer	1.55e-05	0.000428	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MINPP1—thyroid cancer	1.54e-05	0.000425	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—TPR—thyroid cancer	1.52e-05	0.000422	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—RXRA—thyroid cancer	1.51e-05	0.000419	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PRKAR1A—thyroid cancer	1.5e-05	0.000415	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	1.48e-05	0.000409	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—KRAS—thyroid cancer	1.46e-05	0.000404	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MINPP1—thyroid cancer	1.43e-05	0.000397	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.41e-05	0.000391	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PTGS2—thyroid cancer	1.41e-05	0.000389	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.4e-05	0.000387	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HPGD—thyroid cancer	1.4e-05	0.000386	CbGpPWpGaD
Cisplatin—MT2A—Immune System—NRAS—thyroid cancer	1.39e-05	0.000384	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.36e-05	0.000376	CbGpPWpGaD
Cisplatin—XDH—Metabolism—RXRA—thyroid cancer	1.36e-05	0.000376	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NRG1—thyroid cancer	1.34e-05	0.000372	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—SLC5A5—thyroid cancer	1.34e-05	0.000372	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HPGD—thyroid cancer	1.34e-05	0.000371	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TCF7L1—thyroid cancer	1.31e-05	0.000362	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NDUFA13—thyroid cancer	1.31e-05	0.000361	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—RXRA—thyroid cancer	1.3e-05	0.00036	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—thyroid cancer	1.3e-05	0.000359	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.26e-05	0.000348	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—HRAS—thyroid cancer	1.24e-05	0.000343	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CHST14—thyroid cancer	1.23e-05	0.00034	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PTEN—thyroid cancer	1.23e-05	0.00034	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NDUFA13—thyroid cancer	1.22e-05	0.000338	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.22e-05	0.000337	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	1.21e-05	0.000336	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	1.21e-05	0.000336	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TERT—thyroid cancer	1.21e-05	0.000334	CbGpPWpGaD
Cisplatin—MT2A—Immune System—KRAS—thyroid cancer	1.2e-05	0.000331	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.19e-05	0.00033	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	1.18e-05	0.000326	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.17e-05	0.000325	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—TPR—thyroid cancer	1.16e-05	0.000322	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HIF1A—thyroid cancer	1.15e-05	0.000319	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PPARG—thyroid cancer	1.15e-05	0.000319	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CHST14—thyroid cancer	1.15e-05	0.000317	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PRKAR1A—thyroid cancer	1.15e-05	0.000317	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—SLC5A5—thyroid cancer	1.14e-05	0.000316	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.13e-05	0.000313	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—RXRA—thyroid cancer	1.13e-05	0.000312	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.12e-05	0.000311	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.1e-05	0.000304	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—AKT1—thyroid cancer	1.1e-05	0.000303	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—HRAS—thyroid cancer	1.07e-05	0.000297	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.07e-05	0.000296	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—TPR—thyroid cancer	1.05e-05	0.000291	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—TPR—thyroid cancer	1.04e-05	0.000288	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.04e-05	0.000287	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PRKAR1A—thyroid cancer	1.03e-05	0.000286	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	1.02e-05	0.000283	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HRAS—thyroid cancer	1.02e-05	0.000281	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HPGD—thyroid cancer	9.9e-06	0.000274	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PPARG—thyroid cancer	9.8e-06	0.000271	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—RXRA—thyroid cancer	9.59e-06	0.000265	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	9.59e-06	0.000265	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TPR—thyroid cancer	9.57e-06	0.000265	CbGpPWpGaD
Cisplatin—ABCC5—Disease—BRAF—thyroid cancer	9.55e-06	0.000264	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PPARG—thyroid cancer	9.55e-06	0.000264	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	9.55e-06	0.000264	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PRKAR1A—thyroid cancer	9.42e-06	0.000261	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.33e-06	0.000258	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HPGD—thyroid cancer	9.25e-06	0.000256	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.08e-06	0.000251	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTGS2—thyroid cancer	9.07e-06	0.000251	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	9.02e-06	0.00025	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MEN1—thyroid cancer	9e-06	0.000249	CbGpPWpGaD
Cisplatin—MT2A—Immune System—AKT1—thyroid cancer	8.97e-06	0.000248	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SLC5A5—thyroid cancer	8.72e-06	0.000241	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	8.63e-06	0.000239	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PPARG—thyroid cancer	8.57e-06	0.000237	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	8.33e-06	0.00023	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—HRAS—thyroid cancer	8.23e-06	0.000228	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PPARG—thyroid cancer	8.21e-06	0.000227	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.17e-06	0.000226	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—TPR—thyroid cancer	8.02e-06	0.000222	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	8.02e-06	0.000222	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTEN—thyroid cancer	7.91e-06	0.000219	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PRKAR1A—thyroid cancer	7.89e-06	0.000218	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SLC5A5—thyroid cancer	7.87e-06	0.000218	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SLC5A5—thyroid cancer	7.79e-06	0.000216	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTGS2—thyroid cancer	7.72e-06	0.000214	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTGS2—thyroid cancer	7.71e-06	0.000213	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TPR—thyroid cancer	7.71e-06	0.000213	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.63e-06	0.000211	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	7.58e-06	0.00021	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTGS2—thyroid cancer	7.51e-06	0.000208	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.5e-06	0.000208	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—HRAS—thyroid cancer	7.35e-06	0.000203	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—RXRA—thyroid cancer	7.33e-06	0.000203	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CALCA—thyroid cancer	7.17e-06	0.000198	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.15e-06	0.000198	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.13e-06	0.000197	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PPARG—thyroid cancer	7.12e-06	0.000197	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—AKT1—thyroid cancer	7.07e-06	0.000196	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	6.77e-06	0.000187	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—thyroid cancer	6.74e-06	0.000187	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTEN—thyroid cancer	6.73e-06	0.000186	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTEN—thyroid cancer	6.72e-06	0.000186	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—RXRA—thyroid cancer	6.61e-06	0.000183	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTEN—thyroid cancer	6.55e-06	0.000181	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—RXRA—thyroid cancer	6.54e-06	0.000181	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDK1—thyroid cancer	6.49e-06	0.00018	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—thyroid cancer	6.46e-06	0.000179	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.39e-06	0.000177	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PPARG—thyroid cancer	6.06e-06	0.000168	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NRAS—thyroid cancer	6e-06	0.000166	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SLC5A5—thyroid cancer	6e-06	0.000166	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTEN—thyroid cancer	5.88e-06	0.000163	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SLC5A5—thyroid cancer	5.77e-06	0.00016	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TPR—thyroid cancer	5.68e-06	0.000157	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	5.68e-06	0.000157	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTEN—thyroid cancer	5.63e-06	0.000156	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—thyroid cancer	5.6e-06	0.000155	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PRKAR1A—thyroid cancer	5.59e-06	0.000155	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TPR—thyroid cancer	5.31e-06	0.000147	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	5.22e-06	0.000145	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRG1—thyroid cancer	5.21e-06	0.000144	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—thyroid cancer	5.17e-06	0.000143	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—RXRA—thyroid cancer	5.04e-06	0.00014	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.91e-06	0.000136	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTEN—thyroid cancer	4.89e-06	0.000135	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—RXRA—thyroid cancer	4.85e-06	0.000134	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.8e-06	0.000133	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—thyroid cancer	4.76e-06	0.000132	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.74e-06	0.000131	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TERT—thyroid cancer	4.68e-06	0.000129	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PPARG—thyroid cancer	4.63e-06	0.000128	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—thyroid cancer	4.56e-06	0.000126	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HIF1A—thyroid cancer	4.47e-06	0.000124	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—thyroid cancer	4.39e-06	0.000122	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC5A5—thyroid cancer	4.26e-06	0.000118	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPARG—thyroid cancer	4.18e-06	0.000116	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTEN—thyroid cancer	4.15e-06	0.000115	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPARG—thyroid cancer	4.13e-06	0.000114	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC5A5—thyroid cancer	3.98e-06	0.00011	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—thyroid cancer	3.88e-06	0.000107	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—thyroid cancer	3.88e-06	0.000107	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—thyroid cancer	3.78e-06	0.000105	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.72e-06	0.000103	CbGpPWpGaD
Cisplatin—PTGS2—Disease—BRAF—thyroid cancer	3.7e-06	0.000102	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—thyroid cancer	3.64e-06	0.000101	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—RXRA—thyroid cancer	3.58e-06	9.89e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—thyroid cancer	3.39e-06	9.37e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—RXRA—thyroid cancer	3.34e-06	9.24e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—thyroid cancer	3.28e-06	9.09e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—thyroid cancer	3.25e-06	9e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.25e-06	8.99e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—thyroid cancer	3.25e-06	8.99e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPARG—thyroid cancer	3.18e-06	8.81e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTEN—thyroid cancer	3.17e-06	8.78e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPARG—thyroid cancer	3.06e-06	8.47e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTEN—thyroid cancer	2.86e-06	7.93e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTEN—thyroid cancer	2.83e-06	7.84e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—thyroid cancer	2.82e-06	7.79e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTEN—thyroid cancer	2.61e-06	7.22e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—thyroid cancer	2.41e-06	6.66e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—thyroid cancer	2.39e-06	6.63e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRAS—thyroid cancer	2.33e-06	6.44e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPARG—thyroid cancer	2.26e-06	6.25e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTEN—thyroid cancer	2.18e-06	6.05e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPARG—thyroid cancer	2.11e-06	5.84e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTEN—thyroid cancer	2.1e-06	5.81e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—thyroid cancer	2e-06	5.54e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—thyroid cancer	1.83e-06	5.06e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—thyroid cancer	1.78e-06	4.91e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—thyroid cancer	1.7e-06	4.71e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—thyroid cancer	1.66e-06	4.59e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—thyroid cancer	1.65e-06	4.57e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—thyroid cancer	1.63e-06	4.52e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTEN—thyroid cancer	1.55e-06	4.29e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—thyroid cancer	1.5e-06	4.16e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTEN—thyroid cancer	1.45e-06	4e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—thyroid cancer	1.26e-06	3.48e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—thyroid cancer	1.21e-06	3.35e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—thyroid cancer	8.92e-07	2.47e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—thyroid cancer	8.34e-07	2.31e-05	CbGpPWpGaD
